CN116457355B - 2-氨基-3-羰基咪唑并吡啶和吡唑并吡啶化合物 - Google Patents
2-氨基-3-羰基咪唑并吡啶和吡唑并吡啶化合物Info
- Publication number
- CN116457355B CN116457355B CN202180063093.0A CN202180063093A CN116457355B CN 116457355 B CN116457355 B CN 116457355B CN 202180063093 A CN202180063093 A CN 202180063093A CN 116457355 B CN116457355 B CN 116457355B
- Authority
- CN
- China
- Prior art keywords
- pyridin
- amino
- imidazo
- ketone
- fluorocyclopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063078372P | 2020-09-15 | 2020-09-15 | |
| US63/078,372 | 2020-09-15 | ||
| PCT/IB2021/058378 WO2022058890A1 (en) | 2020-09-15 | 2021-09-14 | 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116457355A CN116457355A (zh) | 2023-07-18 |
| CN116457355B true CN116457355B (zh) | 2026-05-08 |
Family
ID=80739409
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180063093.0A Active CN116457355B (zh) | 2020-09-15 | 2021-09-14 | 2-氨基-3-羰基咪唑并吡啶和吡唑并吡啶化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11744824B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4214207A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023541464A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230067669A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116457355B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021342777A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3192158A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022058890A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120603826A (zh) * | 2022-12-30 | 2025-09-05 | 广州市联瑞制药有限公司 | 双环类化合物及其制备方法和应用 |
| KR20260114565A (ko) * | 2023-11-15 | 2026-07-22 | 씨엠에스 리서치 앤드 디벨롭먼트 피티이. 리미티드 | 6,5-융합 헤테로아릴 유도체 및 이의 용도 |
| TW202525805A (zh) * | 2023-12-29 | 2025-07-01 | 大陸商廣州市聯瑞製藥有限公司 | 雙環類化合物及其製備方法和應用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005089763A1 (en) * | 2004-03-19 | 2005-09-29 | Warner-Lambert Company Llc | Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4097483A (en) | 1974-11-01 | 1978-06-27 | Kyorin Pharmaceutical Co., Ltd. | Pyrazolo 1,5-a!pyridines |
| JPS5154583A (en) * | 1974-11-01 | 1976-05-13 | Kyorin Seiyaku Kk | Shinkipirazoro * 1 55a * pirijinjudotaino seizoho |
| KR20080002866A (ko) | 2005-04-25 | 2008-01-04 | 노파르티스 아게 | 펩티드 데포르밀라제 (pdf) 억제제로서 유용한이미다조(1,2-a)피리딘 유도체 |
| PE20070978A1 (es) * | 2006-02-14 | 2007-11-15 | Novartis Ag | COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks) |
| JP5352452B2 (ja) * | 2006-06-06 | 2013-11-27 | メディシノバ, インコーポレイテッド | 置換ピラゾロ[1,5−a]ピリジン化合物およびその使用方法 |
| CA2825746A1 (en) | 2011-01-26 | 2012-08-02 | Kyorin Pharmaceutical Co. Ltd. | Pyrazolopyridine derivative or pharmacologically acceptable salt thereof |
| US20150158868A1 (en) | 2013-12-06 | 2015-06-11 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
| CN108084193A (zh) * | 2017-12-19 | 2018-05-29 | 郭守东 | 一种brd4蛋白抑制剂 |
| KR102906523B1 (ko) * | 2018-09-13 | 2025-12-30 | 브리스톨-마이어스 스큅 컴퍼니 | 수용체-상호작용 단백질 키나제 1 (ripk1) 억제제로서의 1h-인다졸 카르복스아미드 |
-
2021
- 2021-09-14 US US17/474,293 patent/US11744824B2/en active Active
- 2021-09-14 AU AU2021342777A patent/AU2021342777A1/en active Pending
- 2021-09-14 JP JP2023517408A patent/JP2023541464A/ja active Pending
- 2021-09-14 CN CN202180063093.0A patent/CN116457355B/zh active Active
- 2021-09-14 KR KR1020237012894A patent/KR20230067669A/ko active Pending
- 2021-09-14 CA CA3192158A patent/CA3192158A1/en active Pending
- 2021-09-14 WO PCT/IB2021/058378 patent/WO2022058890A1/en not_active Ceased
- 2021-09-14 EP EP21868834.9A patent/EP4214207A4/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005089763A1 (en) * | 2004-03-19 | 2005-09-29 | Warner-Lambert Company Llc | Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents |
Non-Patent Citations (3)
| Title |
|---|
| A. ARQUES 等.The Reaction of 1-Amino-4,6-diphenyl-2-methylthiopyridinium Iodide with Substituted Acetonitriles.《Synthesis》.1981,(第11期),第910-912页,尤其是第910页化合物3b和3c,第911页表格. * |
| R. Belaroussi 等.Three successive and regiocontroled palladium cross-coupling reactions to easily synthesize novel series of 2,4,6-tris(het)aryl pyrido[10,20:1,5]pyrazolo [3,4-d]pyrimidines.《RSC Advances》.2018,(第8期),第732-741页,尤其是第733页流程图1中化合物4和5. * |
| RN:2102411-56-1;ACS;《STN Registry数据库》;20170719;第1页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4214207A4 (en) | 2024-10-02 |
| CN116457355A (zh) | 2023-07-18 |
| JP2023541464A (ja) | 2023-10-02 |
| US11744824B2 (en) | 2023-09-05 |
| US20220087985A1 (en) | 2022-03-24 |
| EP4214207A1 (en) | 2023-07-26 |
| WO2022058890A1 (en) | 2022-03-24 |
| AU2021342777A1 (en) | 2023-04-27 |
| CA3192158A1 (en) | 2022-03-24 |
| KR20230067669A (ko) | 2023-05-16 |
| AU2021342777A9 (en) | 2024-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022228101B2 (en) | Sulfone pyridine alkyl amide-substituted heteroaryl compounds | |
| CN113454082B (zh) | 咪唑并吡啶基化合物及其用于治疗神经退行性疾病的用途 | |
| CN110869360B (zh) | 作为rock抑制剂的苯乙酰胺类 | |
| AU2006232620A1 (en) | Substituted heterocycles and their use as CHK1, PDK1 and PAK inhibitors | |
| AU2025275262A1 (en) | TYK2 inhibitors and uses thereof | |
| EP2181112A1 (en) | Triazolopyridine compounds and their use as ask inhibitors | |
| CA2624649A1 (en) | Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders | |
| CN102341400A (zh) | 用作激酶抑制剂的吡咯并嘧啶化合物 | |
| CN116457355A (zh) | 2-氨基-3-羰基咪唑并吡啶和吡唑并吡啶化合物 | |
| TWI762534B (zh) | 作為PI3Kδ抑制劑的咪唑並[1,5-A]吡衍生物 | |
| WO2016011979A1 (zh) | 2,4-二取代7H-吡咯并[2,3-d]嘧啶衍生物、其制法与医药上的用途 | |
| WO2018229543A2 (en) | Therapeutic inhibitory compounds | |
| CN113768935B (zh) | 免疫疾病的预防剂和/或治疗剂 | |
| JP2016507537A (ja) | 置換アセチレン誘導体およびmGluR4の正のアロステリックモジュレーターとしてのそれらの使用 | |
| EP4200299B1 (en) | Compounds for prevention or treatment of neurodegenerative disorders | |
| HK40096261A (en) | 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds | |
| CN114222744B (zh) | 可用作IL-12、IL-23和/或IFNα反应调节剂的咪唑并哒嗪化合物 | |
| JP2020521818A (ja) | プロテインキナーゼ阻害剤として有用なカルボン酸誘導体 | |
| HK40058868A (en) | Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders | |
| HK40058868B (en) | Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders | |
| EA046543B1 (ru) | Амидзамещенные гетероциклические соединения | |
| HK40058867A (en) | Imidazopyridinyl compounds and use thereof for treatment of proliferative disorders | |
| HK1240121B (en) | Prophylactic and/or therapeutic agent for immune diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40096261 Country of ref document: HK |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |